Home Cart 0 Sign in  
X

[ CAS No. 30379-55-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 30379-55-6
Chemical Structure| 30379-55-6
Chemical Structure| 30379-55-6
Structure of 30379-55-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 30379-55-6 ]

Related Doc. of [ 30379-55-6 ]

Alternatived Products of [ 30379-55-6 ]

Product Details of [ 30379-55-6 ]

CAS No. :30379-55-6 MDL No. :MFCD00274211
Formula : C9H10O3 Boiling Point : -
Linear Structure Formula :- InChI Key :GRZHHTYDZVRPIC-UHFFFAOYSA-N
M.W : 166.17 Pubchem ID :290301
Synonyms :

Calculated chemistry of [ 30379-55-6 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 4
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 43.88
TPSA : 46.53 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.48 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.42
Log Po/w (XLOGP3) : 1.17
Log Po/w (WLOGP) : 1.14
Log Po/w (MLOGP) : 1.1
Log Po/w (SILICOS-IT) : 1.42
Consensus Log Po/w : 1.25

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.85

Water Solubility

Log S (ESOL) : -1.71
Solubility : 3.22 mg/ml ; 0.0193 mol/l
Class : Very soluble
Log S (Ali) : -1.74
Solubility : 3.01 mg/ml ; 0.0181 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.31
Solubility : 0.808 mg/ml ; 0.00486 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.44

Safety of [ 30379-55-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 30379-55-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 30379-55-6 ]
  • Downstream synthetic route of [ 30379-55-6 ]

[ 30379-55-6 ] Synthesis Path-Upstream   1~26

  • 1
  • [ 30379-55-6 ]
  • [ 91183-17-4 ]
Reference: [1] Patent: EP2754659, 2014, A1,
[2] Patent: US2014/378488, 2014, A1,
  • 2
  • [ 30379-55-6 ]
  • [ 109-70-6 ]
  • [ 6940-78-9 ]
YieldReaction ConditionsOperation in experiment
32%
Stage #1: With n-butyllithium; diisopropylamine In tetrahydrofuran; hexane at -70 - -30℃; for 1 h;
Stage #2: at -70 - 20℃; for 2.5 h;
To a solution of diisopropylamine (1.1 mL, 8.0 mmol) in THF (10 mL) was added dropwise n-butyllithium 1.6 M hexane solution (5.0 mL, 8.0 mmol) at -30°C, and the mixture was stirred at the same temperature for 30 min. Thereto was added dropwise a solution of (benzyloxy)acetic acid (0.60 g, 3.6 mmol) in THF (5 mL) at -70°C, and the mixture was stirred at the same temperature for 30 min. Further, at the same temperature, 1-bromo-3-chloropropane (3.6 mL, 36 mmol) was added, and the mixture was stirred at the same temperature for 30 min and then at room temperature for 2 hr. The reaction mixture was added to ice-cooled water, and the mixture was washed with ethyl acetate. The aqueous layer was adjusted to pH 3 - 4 with 6 M hydrochloric acid, and the mixture was extracted with ethyl acetate. The organic layer was washed with saturated brine, dried over anhydrous magnesium sulfate, and the solvent was evaporated under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane/ethyl acetate=100/0 - 50/50) to give the title compound as a colorless oil (0.28 g, 32percent). 1H NMR (CDCl3) δ: 1. 91 - 2.06 (4 H, m), 3.54 (2 H, t, J=5.1 Hz), 4.08 (1 H, t, J=6.6 Hz), 4.55 and 4.74 (2 H, d, J=11.4 Hz), 7.34 - 7.39 (5 H, m).
Reference: [1] Patent: EP2455380, 2012, A1, . Location in patent: Page/Page column 79
  • 3
  • [ 79-11-8 ]
  • [ 100-51-6 ]
  • [ 30379-55-6 ]
YieldReaction ConditionsOperation in experiment
88.3% With potassium hydroxide In tetrahydrofuran; toluene at 70 - 80℃; Large scale 960 g of tetrahydroffiran and 41 g of toluene were added into a reaction flask. While controlling the temperature of the system at 10-20° C., 534.0 g of potassium hydroxide was added in four portions. Afier the addition of potassium hydroxide was completed, 1371.1 g of benzyl alcohol was added into the system in three portions. 300.1 g of chloroacetic acid was dissolved in 480.5 g of tetrahydrofuran, and the solution of chloroacetic acid in tetrahydrofuran was added dropwise into the above system while maintaining the temperature at 70-80° C. The system was reacted until chloroacetic acid was completely consumed. After cooling the system down, 3.12 Kg of purified water was added and tetrahydroffiran was removed under reduced pressure. The aqueous phase was extracted four times with toluene, and adjusted with hydrochloric acid at 10-20° C. to pH 3. The aqueous phase was extracted twice with methyl tert-butyl ether, and then concentrated to give 421.3 g of benzyloxyacetic acid (compound 3). The yield was 88.3percent, and the GC purity was 99.2percent. H1 NMR (400 MHz, CDCl3) δ: 12.28 (br, 1H),7.34-7.30 (m, 5H), 4.59 (s, 2H), 4.12 (s, 2H).
Reference: [1] Chemistry - A European Journal, 1999, vol. 5, # 1, p. 121 - 161
[2] Tetrahedron, 2002, vol. 58, # 38, p. 7663 - 7679
[3] European Journal of Organic Chemistry, 2017, vol. 2017, # 3, p. 695 - 703
[4] Patent: US2017/190684, 2017, A1, . Location in patent: Paragraph 0065; 0066; 0081
[5] Journal of the American Chemical Society, 2003, vol. 125, # 13, p. 3793 - 3798
[6] Tetrahedron Letters, 2008, vol. 49, # 23, p. 3762 - 3765
[7] Zhurnal Obshchei Khimii, 1954, vol. 24, p. 642,645; engl. Ausg. S. 651, 654
[8] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1983, # 10, p. 2479 - 2483
[9] Bulletin de la Societe Chimique de France, 1993, vol. 130, # 3, p. 388 - 394
[10] Journal of Organometallic Chemistry, 1997, vol. 530, # 1-2, p. 149 - 158
[11] Journal of the American Chemical Society, 2002, vol. 124, # 42, p. 12426 - 12427
[12] Patent: WO2005/35541, 2005, A1, . Location in patent: Page/Page column 15
[13] Organic and Biomolecular Chemistry, 2012, vol. 10, # 8, p. 1598 - 1601
[14] Patent: WO2013/189980, 2013, A1, . Location in patent: Page/Page column 31
[15] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 10, p. 2305 - 2308
  • 4
  • [ 79-08-3 ]
  • [ 100-51-6 ]
  • [ 30379-55-6 ]
Reference: [1] Chemistry - A European Journal, 2014, vol. 20, # 15, p. 4460 - 4468
[2] Tetrahedron Letters, 1987, vol. 28, # 7, p. 797 - 800
[3] European Journal of Organic Chemistry, 2008, # 14, p. 2375 - 2387
[4] European Journal of Organic Chemistry, 2006, # 21, p. 4910 - 4915
[5] Tetrahedron Letters, 2008, vol. 49, # 23, p. 3762 - 3765
[6] Tetrahedron Letters, 1985, vol. 26, # 10, p. 1343 - 1344
[7] Synlett, 1999, # 6, p. 692 - 694
[8] Organic Letters, 2007, vol. 9, # 23, p. 4865 - 4868
[9] Synlett, 2009, # 4, p. 653 - 657
[10] Organic Letters, 2010, vol. 12, # 5, p. 1120 - 1123
[11] Journal of Organic Chemistry, 2011, vol. 76, # 9, p. 3576 - 3581
[12] Journal of Medicinal Chemistry, 2017, vol. 60, # 12, p. 5162 - 5192
  • 5
  • [ 30379-54-5 ]
  • [ 30379-55-6 ]
Reference: [1] Tetrahedron Letters, 1992, vol. 33, # 17, p. 2299 - 2302
[2] Bulletin de la Societe Chimique de France, 1970, p. 4018 - 4023
  • 6
  • [ 32122-09-1 ]
  • [ 30379-55-6 ]
Reference: [1] Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1953, vol. 237, p. 1162
[2] Medicinal Chemistry Research, 2004, vol. 13, # 8-9, p. 660 - 676
[3] Patent: EP569598, 1993, A1,
[4] Organic Letters, 2011, vol. 13, # 21, p. 5762 - 5765
  • 7
  • [ 124-38-9 ]
  • [ 66222-28-4 ]
  • [ 30379-55-6 ]
Reference: [1] Synthetic Communications, 1998, vol. 28, # 20, p. 3727 - 3741
  • 8
  • [ 3926-62-3 ]
  • [ 20194-18-7 ]
  • [ 30379-55-6 ]
Reference: [1] Synthetic Communications, 1992, vol. 22, # 3, p. 411 - 420
  • 9
  • [ 1400787-39-4 ]
  • [ 30379-55-6 ]
Reference: [1] Organic Letters, 2012, vol. 14, # 19, p. 5010 - 5013
  • 10
  • [ 79-08-3 ]
  • [ 20194-18-7 ]
  • [ 30379-55-6 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1983, p. 1213 - 1218
[2] Tetrahedron Letters, 2003, vol. 44, # 41, p. 7649 - 7653
  • 11
  • [ 100-51-6 ]
  • [ 30379-55-6 ]
Reference: [1] Patent: US2068905, 1936, ,
[2] Patent: US2068905, 1936, ,
  • 12
  • [ 105-39-5 ]
  • [ 100-51-6 ]
  • [ 30379-55-6 ]
Reference: [1] Journal of Organic Chemistry, 1961, vol. 26, p. 194 - 197
[2] Archiv der Pharmazie, 1979, vol. 312, # 3, p. 240 - 247
[3] Journal of Organic Chemistry, 1984, vol. 49, # 25, p. 5003 - 5006
  • 13
  • [ 31600-43-8 ]
  • [ 30379-55-6 ]
Reference: [1] Journal of Organometallic Chemistry, 1997, vol. 530, # 1-2, p. 149 - 158
  • 14
  • [ 79-11-8 ]
  • [ 100-51-6 ]
  • [ 30379-55-6 ]
  • [ 65-85-0 ]
Reference: [1] Tetrahedron Letters, 2008, vol. 49, # 23, p. 3762 - 3765
  • 15
  • [ 935-04-6 ]
  • [ 30379-55-6 ]
  • [ 60656-87-3 ]
Reference: [1] Letters in Organic Chemistry, 2016, vol. 13, # 9, p. 652 - 656
  • 16
  • [ 100-44-7 ]
  • [ 30379-55-6 ]
Reference: [1] Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1953, vol. 237, p. 1162
  • 17
  • [ 20194-18-7 ]
  • [ 30379-55-6 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1970, p. 4018 - 4023
  • 18
  • [ 2785-29-7 ]
  • [ 105-39-5 ]
  • [ 30379-55-6 ]
Reference: [1] Journal of the Chemical Society, 1957, p. 1062,1063
  • 19
  • [ 30379-55-6 ]
  • [ 19810-31-2 ]
YieldReaction ConditionsOperation in experiment
100% With oxalyl dichloride; N,N-dimethyl-formamide In dichloromethane at 20℃; for 5 h; Example 1(a)
Benzyloxy acetyl chloride
To benzyloxyacetic acid (10.0 g, 60.0 mmol, 8.6 mL) in dichloromethane (50 mL) was added oxalyl chloride (9.1 g, 72.0 mmol, 6.0 mL) and DMF (30.0 mg, 0.4 mmol, 32.0 μL) and stirred at RT for 3 h. There was initially a rapid evolution of gas as the reaction proceeded but evolution ceased as the reaction was complete. The dichloromethane solution was concentrated in vacuo to give a gum. This gum was treated with more oxalyl chloride (4.5 g, 35.7 mmol, 3.0 mL), dichloromethane (50 mL), and one drop of DMF. There was a rapid evolution of gas and the reaction was stirred for a further 2 h. The reaction was then concentrated in vacuo to afford 11.0 g (quantitative) of Benzyloxy acetyl chloride (1) as a gum. The structure was confirmed by 13C NMR (75 MHz, CDCl3) δC 73.6, 74.8, 128.1, 128.4, 128.6, 130.0, and 171.9.
100% With oxalyl dichloride; N,N-dimethyl-formamide In dichloromethane at 20℃; for 2 h; To benzyloxyacetic acid (10.0 g, 60.0 mmol, 8.6 mL) in dichloromethane (50 mL) was added oxalyl chloride (9.1 g, 72.0 mmol, 6.0 mL) and DMF (30.0 mg, 0.4 mmol, 32.0 μ) and stirred at RT for 3 h. There was initially a rapid evolution of gas as the reaction proceeded but evolution ceased as the reaction was complete. The dichloromethane solution was concentrated in vacuo to give a gum. This gum was treated with more oxalyl chloride (4.5 g, 35.7 mmol, 3.0 mL), dichloromethane (50 mL), and one drop of DMF. There was a rapid evolution of gas and the reaction was stirred for a further 2 h. The reaction was then concentrated in vacuo to afford 11.0 g (quantitative) of Benzyloxy acetyl chloride as a gum. The structure was confirmed by 13C NMR (75 MHz, CDC13) 5c 73.6, 74.8, 128.1, 128.4, 128.6, 130.0, and 171.9.
100% With oxalyl dichloride; N,N-dimethyl-formamide In dichloromethane at 20℃; for 5 h; To benzyloxyacetic acid (10.0 g, 60.0 mmol, 8.6 mL) in dichloromethane (50 mL) wasadded oxalyl chloride (9.1 g, 72.0 mmol, 6.0 mL) and DMF (30.0 mg, 0.4 mmol, 32.0μL) and stuffed at RT for 3 h. There was initially a rapid evolution of gas as the reaction proceeded but evolution ceased as the reaction was complete. The dichloromethane solution was concentrated in vacuo to give a gum. This gum was treated with more oxalyl chloride (4.5 g, 35.7 mmol, 3.0 mL), dichloromethane (50 mL), and one drop of DMF.There was a rapid evolution of gas and the reaction was stuffed for a further 2 h. The reaction was then concentrated in vacuo to afford 11.0 g (quantitative) of Benzyloxy acetyl chloride (1) as a gum. The structure was confirmed by 13C NMR (75 MHz, CDCl3) δc 73.6, 74.8, 128.1, 128.4, 128.6, 130.0, and 171.9.
100% With oxalyl dichloride; N,N-dimethyl-formamide In dichloromethane at 20℃; for 5 h; To benzyloxyacetic acid (10.0 g, 60.0 mmol, 8.6 mL) in dichloromethane (50 mL) was added oxalyl chloride (9.1 g, 72.0 mmol, 6.0 mL) and DMF (30.0 mg, 0.4 mmol, 32.0 μL) and stirred at RT for 3 h. There was initially a rapid evolution of gas as the reaction proceeded but evolution ceased as the reaction was complete. The dichloromethane solution was concentrated in vacuo to give a gum. This gum was treated with more oxalyl chloride (4.5 g, 35.7 mmol, 3.0 mL), dichloromethane (50 mL), and one drop of DMF. There was a rapid evolution of gas and the reaction was stirred for a further 2 h. The reaction was then concentrated in vacuo to afford 11.0 g (quantitative) of Benzyloxy acetyl chloride (1) as a gum. The structure was confirmed by 13C NMR (75 MHz, CDCl3) δC 73.6, 74.8, 128.1, 128.4, 128.6, 130.0, and 171.9.
100% With oxalyl dichloride; N,N-dimethyl-formamide In dichloromethane at 20℃; for 5 h; Example 1(a) Benzyloxy Acetyl Chloride (1) (0158) To benzyloxyacetic acid (10.0 g, 60.0 mmol, 8.6 mL) in dichloromethane (50 mL) was added oxalyl chloride (9.1 g, 72.0 mmol, 6.0 mL) and DMF (30.0 mg, 0.4 mmol, 32.0 μL) and stirred at RT for 3 h. There was initially a rapid evolution of gas as the reaction proceeded but evolution ceased as the reaction was complete. The dichloromethane solution was concentrated in vacuo to give a gum. This gum was treated with more oxalyl chloride (4.5 g, 35.7 mmol, 3.0 mL), dichloromethane (50 mL), and one drop of DMF. There was a rapid evolution of gas and the reaction was stirred for a further 2 h. The reaction was then concentrated in vacuo to afford 11.0 g (quantitative) of Benzyloxy acetyl chloride (1) as a gum. The structure was confirmed by 13C NMR (75 MHz, CDCl3) bc 73.6, 74.8, 128.1, 128.4, 128.6, 130.0, and 171.9.

Reference: [1] Patent: US2013/177501, 2013, A1, . Location in patent: Paragraph 0152
[2] Patent: WO2015/7834, 2015, A1, . Location in patent: Page/Page column 17
[3] Patent: WO2015/40087, 2015, A1, . Location in patent: Page/Page column 13; 14
[4] Patent: US9168317, 2015, B2, . Location in patent: Page/Page column 20
[5] Patent: US9314541, 2016, B2, . Location in patent: Page/Page column 21
[6] European Journal of Organic Chemistry, 2017, vol. 2017, # 3, p. 695 - 703
[7] European Journal of Organic Chemistry, 2008, # 14, p. 2375 - 2387
[8] Journal of the American Chemical Society, 2003, vol. 125, # 13, p. 3793 - 3798
[9] European Journal of Organic Chemistry, 2006, # 21, p. 4910 - 4915
[10] European Journal of Organic Chemistry, 2017, vol. 2017, # 38, p. 5789 - 5794
[11] Journal of Organic Chemistry, 1984, vol. 49, # 25, p. 5003 - 5006
[12] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1984, # 1, p. 29 - 39
[13] Helvetica Chimica Acta, 1933, vol. 16, p. 1130,1138
[14] Journal of Organic Chemistry, 1961, vol. 26, p. 194 - 197
[15] Journal of Organic Chemistry, 1983, vol. 48, # 26, p. 5221 - 5228
[16] Bulletin de la Societe Chimique de France, 1993, vol. 130, # 3, p. 388 - 394
[17] Tetrahedron Letters, 1994, vol. 35, # 39, p. 7269 - 7272
[18] Synlett, 1999, # 6, p. 692 - 694
[19] Chemistry - A European Journal, 1999, vol. 5, # 1, p. 121 - 161
[20] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 3, p. 771 - 775
[21] Organic Letters, 2003, vol. 5, # 4, p. 591 - 594
[22] Organic Letters, 2007, vol. 9, # 23, p. 4865 - 4868
[23] Journal of Organic Chemistry, 2008, vol. 73, # 6, p. 2105 - 2113
[24] Synlett, 2009, # 4, p. 653 - 657
[25] Journal of the American Chemical Society, 2008, vol. 130, # 51, p. 17270 - 17271
[26] Synthesis, 2010, # 14, p. 2407 - 2412
[27] Tetrahedron, 2009, vol. 65, # 33, p. 6720 - 6729
[28] Tetrahedron Letters, 2011, vol. 52, # 16, p. 1909 - 1912
[29] Organic Letters, 2011, vol. 13, # 21, p. 5762 - 5765
[30] Organic and Biomolecular Chemistry, 2012, vol. 10, # 8, p. 1598 - 1601
[31] Journal of Medicinal Chemistry, 2017, vol. 60, # 12, p. 5162 - 5192
[32] Chemistry - A European Journal, 2017, vol. 23, # 54, p. 13314 - 13318
[33] Chemistry - A European Journal, 2018, vol. 24, # 52, p. 13947 - 13953
[34] Patent: CN107383007, 2017, A, . Location in patent: Paragraph 0006; 0012
[35] Patent: WO2006/103555, 2006, A1, . Location in patent: Page/Page column 101-102
  • 20
  • [ 79-37-8 ]
  • [ 30379-55-6 ]
  • [ 19810-31-2 ]
Reference: [1] Patent: US2011/70161, 2011, A1,
[2] Patent: US9220795, 2015, B2,
  • 21
  • [ 67-56-1 ]
  • [ 30379-55-6 ]
  • [ 31600-43-8 ]
YieldReaction ConditionsOperation in experiment
92% at 4 - 20℃; A solution of 2-(benzyloxy)acetic acid (25.0 g, 150 mmol) in MeOH (500 mL) was cooled to 4 0C in an ice-water bath. Thionyl chloride (13.0 mL, 179 mmol) was added drop-wise via an addition funnel at a rate to maintain the temperature below 8 0C. The resulting solution was stirred for 30 min. at 4 0C and 2.5 hr. at room temperature. The solvent was evaporated under reduced pressure and the resulting residue was dissolved in EtOAc (200 mL) and washed with sat. aq. NaHCO3 (200 mL). The aqueous layer was extracted with an additional portion of EtOAc (100 mL) and the organic layers were combined, washed with brine (200 mL), dried over Na2SO4, filtered, and evaporated under reduced pressure to afford 27.6 g (92 percent) of methyl 2-(benzyloxy)acetate as a clear, colorless liquid. 1H NMR (OMSO-d6, 400 MHz): δ 7.26-7.41 (m, 5 H), 4.54 (s, 2H), 4.18 (s, 2H), 3.67 (s, 3H).
90%
Stage #1: at 0℃; for 1 h;
Stage #2: at 60℃; for 3 h;
[00458] Thionyl chloride (17.2 g) was added to methanol (100 mL ) at 0 °C. After stirring for 1 h, 2-(benzyloxy)acetic acid (111) (8.0 g, 48.2 mmol) was added. The mixture was stirred at 60 °C for 3 h, and concentrated to give methyl 2-(benzyloxy)acetate (112) (Yield 7.8 g, 90percent), which was used in the next step without further purification. LCMS: m/z 181.1 [M+H]+; tR = 0.84 min.
18.1 g at 70℃; for 2 h; A mixture of 2- (benzyloxy) acetic acid (20 g) and H2S04 (10 L) in MeOH (200 mL) was stirred at 70°C for 2 hr and evaporated The residue was treated with saturated NaHC03 solution, and extracted with AcOEt. The organic layer was dried over MgS04, passed through silica gel pad and concentrated under reduced pressure to give the title compound (18.1 g) . ""H-NMR (300 MHz, DMSO-d6) δ 3.67 (3H, s) , 4.17 (2H, s) , 4.54 (2H, s) , 7.16-7.54 (5H, m) .
7.9 g for 16 h; Reflux 2-(benzyloxy)acetic acid (11.5 g, 69.2 mmol) in methanol (69 mL) with a catalytic amount ofconcentrated sulfuric acid was heated under reflux for 16 h. The reaction was cooled to rt andwater and MTBE were added. The aqueous layer was extracted with MTBE and the combinedorganic layers were dried and the solvent removed under reduced pressure to give 7.9 g of themethyl ester.20 1H NMR (500MHz, CDCI3): o = 7.38-7.34 (m, 4H), 7.31 (m, 1 H), 4.63 (s, 2H), 4.11 (s, 2H), 3. 76(s, 3H).
200 g at 0℃; for 6 h; Inert atmosphere; Reflux Step A - Synthesis of Intermediate Compound lb To a solution of compound la (200g, 1.2 mol) in dry Methanol (2 L) was added SOCI2 (424 g, 3.6 mol) under 2 at 0 °C, then heated under reflux for 6 hours. The reaction mixture was concentrated in vacuo and the resulting residue was dissolved in EtOAc (3 L). The organic phase was washed with NaHCCh (2 L*2), brine, dried over a2S04 and concentrated in vacuo to provide compound lb (200 g) as an oil.

Reference: [1] Chemistry - A European Journal, 1999, vol. 5, # 1, p. 121 - 161
[2] European Journal of Organic Chemistry, 2006, # 6, p. 1489 - 1498
[3] Patent: WO2010/127272, 2010, A2, . Location in patent: Page/Page column 86; 87
[4] Angewandte Chemie - International Edition, 2014, vol. 53, # 5, p. 1334 - 1337[5] Angew. Chem., 2014, vol. 126, # 5, p. 1358 - 1361
[6] Patent: WO2015/42414, 2015, A1, . Location in patent: Paragraph 00458
[7] Patent: WO2013/27845, 2013, A1, . Location in patent: Paragraph 0444
[8] Patent: WO2013/189980, 2013, A1, . Location in patent: Page/Page column 31
[9] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 10, p. 2305 - 2308
[10] Patent: WO2014/99586, 2014, A1, . Location in patent: Page/Page column 28; 29
[11] Patent: US2014/194431, 2014, A1, . Location in patent: Paragraph 0127-0129
[12] Patent: WO2015/95258, 2015, A1, . Location in patent: Page/Page column 56
[13] Patent: WO2015/89847, 2015, A1, . Location in patent: Page/Page column 34
  • 22
  • [ 186581-53-3 ]
  • [ 30379-55-6 ]
  • [ 31600-43-8 ]
Reference: [1] Journal of Organometallic Chemistry, 1997, vol. 530, # 1-2, p. 149 - 158
[2] Helvetica Chimica Acta, 1958, vol. 41, p. 768
[3] Synthetic Communications, 1998, vol. 28, # 20, p. 3727 - 3741
[4] Organic Letters, 2012, vol. 14, # 19, p. 5010 - 5013
  • 23
  • [ 64-17-5 ]
  • [ 30379-55-6 ]
  • [ 32122-09-1 ]
YieldReaction ConditionsOperation in experiment
90% Inert atmosphere; Reflux Step 1 A catalytic amount of concentrated sulfuric acid was added to Compound 10a (33.2 g, 0.2 mol) in ethanol (300 mL) solution. The reaction was heated to reflux overnight. The solvent was concentrated, and the resulting residue was dissolved into ethyl acetate, and then washed with saturated aqueous sodium bicarbonate solution. The organic phase was collected and dried over anhydrous sodium sulfate. The solvent was concentrated to obtain Compound 10b (35 g, Yield 90percent).
90% With sulfuric acid In ethanolInert atmosphere; Reflux A catalytic amount of concentrated sulfuric acid was added to Compound lOa (33.2 g, 0.2 mol) in ethanol (300 mE) solution. The reaction was heated to reflux overnight. The solvent was concentrated, and the resulting residue was dissolved into ethyl acetate, and then washed with saturated aqueous sodium bicarbonate solution. The organic phase was collected and dried over anhydrous sodium sulfate. The solvent was concentrated to obtain Compound lOb (35 g, Yield
Reference: [1] Patent: EP2754659, 2014, A1, . Location in patent: Paragraph 0168-0170
[2] Patent: US2014/378488, 2014, A1, . Location in patent: Paragraph 0380; 0381; 0382
[3] Journal of Medicinal Chemistry, 2013, vol. 56, # 2, p. 437 - 450
[4] Scientia Sinica (English Edition), 1957, vol. 6, p. 279,289[5] Huaxue Xuebao, 1956, vol. 22, p. 542
  • 24
  • [ 30379-55-6 ]
  • [ 74-88-4 ]
  • [ 33106-32-0 ]
Reference: [1] Tetrahedron, 2002, vol. 58, # 38, p. 7663 - 7679
[2] Organic Letters, 2014, vol. 16, # 20, p. 5278 - 5281
  • 25
  • [ 74-83-9 ]
  • [ 30379-55-6 ]
  • [ 33106-32-0 ]
Reference: [1] Synthesis, 1978, p. 828 - 829
  • 26
  • [ 30379-55-6 ]
  • [ 100836-85-9 ]
Reference: [1] Tetrahedron Letters, 2001, vol. 42, # 10, p. 1835 - 1838
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 30379-55-6 ]

Aryls

Chemical Structure| 31600-43-8

[ 31600-43-8 ]

Methyl 2-(benzyloxy)acetate

Similarity: 0.94

Chemical Structure| 32122-09-1

[ 32122-09-1 ]

Ethyl 2-(benzyloxy)acetate

Similarity: 0.92

Chemical Structure| 30379-58-9

[ 30379-58-9 ]

Benzyl 2-hydroxyacetate

Similarity: 0.89

Chemical Structure| 60656-87-3

[ 60656-87-3 ]

2-(Benzyloxy)acetaldehyde

Similarity: 0.88

Chemical Structure| 100836-85-9

[ 100836-85-9 ]

(R)-2-(Benzyloxy)propanoic acid

Similarity: 0.85

Ethers

Chemical Structure| 31600-43-8

[ 31600-43-8 ]

Methyl 2-(benzyloxy)acetate

Similarity: 0.94

Chemical Structure| 32122-09-1

[ 32122-09-1 ]

Ethyl 2-(benzyloxy)acetate

Similarity: 0.92

Chemical Structure| 60656-87-3

[ 60656-87-3 ]

2-(Benzyloxy)acetaldehyde

Similarity: 0.88

Chemical Structure| 33106-32-0

[ 33106-32-0 ]

(S)-2-(Benzyloxy)propanoic acid

Similarity: 0.85

Chemical Structure| 100836-85-9

[ 100836-85-9 ]

(R)-2-(Benzyloxy)propanoic acid

Similarity: 0.85

Carboxylic Acids

Chemical Structure| 33106-32-0

[ 33106-32-0 ]

(S)-2-(Benzyloxy)propanoic acid

Similarity: 0.85

Chemical Structure| 100836-85-9

[ 100836-85-9 ]

(R)-2-(Benzyloxy)propanoic acid

Similarity: 0.85

Chemical Structure| 88920-24-5

[ 88920-24-5 ]

2-((4-Methoxybenzyl)oxy)acetic acid

Similarity: 0.83

Chemical Structure| 68858-21-9

[ 68858-21-9 ]

4-(Hydroxymethyl)phenoxyacetic acid

Similarity: 0.79

Chemical Structure| 97388-49-3

[ 97388-49-3 ]

2-(2-(Hydroxymethyl)phenoxy)acetic acid

Similarity: 0.77